TRCT
ENSC icon

Tower Research Capital (TRC)’s Ensysce Biosciences ENSC Stock Holding History

Tower Research Capital (TRC)’s Portfolio ENSC Stock Details ENSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77K Hold
6,094
– – ﹤0.01% 4771
2026
Q1 		$3.28K Buy
6,094
+775
+15% +$491 ﹤0.01% 4338
2025
Q4 		$4.89K Buy
5,319
+3,971
+295% +$7.37K ﹤0.01% 4169
2025
Q3 		$3.19K Sell
1,348
-21
-2% -$45 ﹤0.01% 4534
2025
Q2 		$3.05K Buy
1,369
+928
+210% +$2.13K ﹤0.01% 4559
2025
Q1 		$1.13K Buy
441
+3
+0.7% +$17 ﹤0.01% 4770
2024
Q4 		$3.56K Buy
438
+8
+2% +$55 ﹤0.01% 4638
2024
Q3 		$1.55K Sell
430
-120
-22% -$728 ﹤0.01% 5138
2024
Q2 		$4.19K Buy
550
+6
+1% +$55 ﹤0.01% 4808
2024
Q1 		$6.45K Buy
544
+124
+30% +$1.97K ﹤0.01% 4367
2023
Q4 		$6.68K Buy
420
+158
+60% +$2.54K ﹤0.01% 4710
2023
Q3 		$5.42K Buy
262
+2
+0.8% +$57 ﹤0.01% 4721
2023
Q2 		$7.02K Buy
260
+216
+491% +$9.77K ﹤0.01% 4632
2023
Q1 		$3K Buy
44
+40
+1,000% +$4.59K ﹤0.01% 5185
2022
Q4 		$1K Hold
4
– – ﹤0.01% 5580
2022
Q3 		$3K Buy
4
+3
+300% +$4.89K ﹤0.01% 5383
2022
Q2 		$3K Sell
1
-2
-67% -$5.6K ﹤0.01% 5367
2022
Q1 		$12K Sell
3
-6
-67% -$39.7K ﹤0.01% 4053
2021
Q4 		$153K Buy
9
+6
+200% +$56.5K ﹤0.01% 1959
2021
Q3 		$32K Buy
+3
New +$58.6K ﹤0.01% 3305

Other funds holding ENSC

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TIAM2
Tru Independence Asset Management 2 Portland, Oregon $185M AUM 20.3% 1-Year Est. Return

Tower Research Capital (TRC)'s ENSC Position: Q2 2026 in Review

Tower Research Capital (TRC) held its Ensysce Biosciences (ENSC) position steady in Q2 2026 at 6,094 shares worth $1.77K. The position accounts for ﹤0.01% of the portfolio, ranked #4771.

Tower Research Capital (TRC) first reported a position in ENSC in Q3 2021 and has held it in 20 quarters since. The position peaked at $153K in Q4 2021. 18 funds tracked by Wall St. Rank hold ENSC as of Q2 2026.

  • Tower Research Capital (TRC) held 6,094 shares of Ensysce Biosciences worth $1.77K as of Q2 2026.
  • Tower Research Capital (TRC) left its Ensysce Biosciences share count unchanged in Q2 2026.
  • Ensysce Biosciences made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4771 holding.
  • Tower Research Capital (TRC) first reported a position in Ensysce Biosciences in Q3 2021 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s Ensysce Biosciences position peaked at $153K in Q4 2021.
  • 18 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.